GlassScriptPhysician profile
Megan E Athey
NPI 1649955675
$722.99
in general payments reported to CMS, 2019-2025
13 companies · $161 in 2025
The $161 reported for 2025 was more than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $167 · 2024: $395 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $722.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $197.47 | 2023-2025 | Veozah |
| Optumhealth Care Solutions, LLC | $153.42 | 2023-2024 | Eitan Medical, Vivify Health Care Team Portal 001, Zyno Solutions |
| Hologic Sales and Service, LLC | $73.37 | 2023-2025 | Aptima |
| Mayne Pharma Commercial LLC | $69.29 | 2024-2025 | |
| Exact Sciences Corporation | $52.09 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Coopersurgical, INC. | $35.25 | 2024-2025 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $33.78 | 2024-2025 | |
| Dexcom, INC. | $24.01 | 2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $19.88 | 2025 | Zepbound, Mounjaro |
| Organon LLC | $19.09 | 2023 | Nexplanon |
| Exeltis, USA INC. | $17.81 | 2024 | Slynd |
| Pfizer INC. | $14.22 | 2024 | |
| Sage Therapeutics, LLC | $13.31 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Athey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.